<?xml version="1.0" encoding="iso-8859-1"?>
<!-- generator="FeedCreator 1.7.2" -->
<rss version="2.0">
    <channel>
        <title>MedWorm Tags: adverse drug reactions</title>
        <description>MedWorm provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest medical blog items that have been tagged with 'adverse drug reactions'.</description>
        <link><![CDATA[http://www.medworm.com/rss/search.php?qu=%22adverse+drug+reactions%22&t=%22adverse+drug+reactions%22&r=Exact&o=d&f=tag]]></link>
        <lastBuildDate>Sat, 03 Sep 2011 02:47:55 +0100</lastBuildDate>
        <item>
            <title>Safety in second place?</title>
            <link>http://www.medworm.com/index.php?rid=4214185&amp;cid=t_97449_109_f&amp;fid=34504&amp;url=http%3A%2F%2Fwww.blacktriangle.org%2Fblog%2F%3Fp%3D2163</link>
            <description>The safety of newly marketed drugs is always provisional, based on the relatively limited population the drugs are used in prior to marketing. The number of subjects who take a drug in clinical trials is large enough to detect efficacy, but too small to detect rare, but serious, adverse events. In addition, the patients are [...] (Source: Black Triangle)</description>
            <author>Black Triangle</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4214185</comments>
            <pubDate>Tue, 30 Nov 2010 09:43:21 +0100</pubDate>
            <guid isPermaLink="false">4214185</guid>        </item>
        <item>
            <title>Paracetamol: Recall bias and media bias</title>
            <link>http://www.medworm.com/index.php?rid=4022951&amp;cid=t_97449_109_f&amp;fid=34504&amp;url=http%3A%2F%2Fwww.blacktriangle.org%2Fblog%2F%3Fp%3D2130</link>
            <description>Just a short note. A couple of years ago there was a great deal of fuss about paracetamol and a possible link with asthma in children [Lancet]. The study reported on was a large retrospective study (205 487 children) involving surveying parents about their children&amp;#8217;s previous paracetamol use and symptoms of asthma. There is an [...] (Source: Black Triangle)</description>
            <author>Black Triangle</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4022951</comments>
            <pubDate>Fri, 01 Oct 2010 15:39:20 +0100</pubDate>
            <guid isPermaLink="false">4022951</guid>        </item>
        <item>
            <title>Side effects</title>
            <link>http://www.medworm.com/index.php?rid=3934499&amp;cid=t_97449_109_f&amp;fid=34504&amp;url=http%3A%2F%2Fwww.blacktriangle.org%2Fblog%2F%3Fp%3D2102</link>
            <description>(Source: Black Triangle)</description>
            <author>Black Triangle</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3934499</comments>
            <pubDate>Sat, 04 Sep 2010 10:24:50 +0100</pubDate>
            <guid isPermaLink="false">3934499</guid>        </item>
        <item>
            <title>Fly posting</title>
            <link>http://www.medworm.com/index.php?rid=2865723&amp;cid=t_97449_109_f&amp;fid=34504&amp;url=http%3A%2F%2Fwww.blacktriangle.org%2Fblog%2F%3Fp%3D2029</link>
            <description>I&amp;#8217;m presenting a couple of posters at the International Society of Pharmacovigilance Conference this week. One is concerned with possible neuropsychiatric reactions to varenicline, and the other uses the DoTS ADR classification system to analyse reports of angioedema with angiotensin-II receptor antagonists. Further details at the links in the text. (Source: Black Triangle)</description>
            <author>Black Triangle</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2865723</comments>
            <pubDate>Tue, 06 Oct 2009 10:24:22 +0100</pubDate>
            <guid isPermaLink="false">2865723</guid>        </item>
        <item>
            <title>What a difference a day makes to the efficacy of oseltamivir (Tamiflu)</title>
            <link>http://www.medworm.com/index.php?rid=2688738&amp;cid=t_97449_109_f&amp;fid=34504&amp;url=http%3A%2F%2Fwww.blacktriangle.org%2Fblog%2F%3Fp%3D2010</link>
            <description>many of those prescribed Tamiflu are stockpiling it to be sure of having access to the powerful drug

Independent 10th of August
Doctors should stop giving Tamiflu to children as a routine treatment for swine flu, researchers concluded after finding the drug can cause more harm than good.

Independent 11th of August
To be fair, no wonder people are [...] (Source: Black Triangle)</description>
            <author>Black Triangle</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2688738</comments>
            <pubDate>Tue, 11 Aug 2009 07:30:10 +0100</pubDate>
            <guid isPermaLink="false">2688738</guid>        </item>
        <item>
            <title>The adverse effects of neuraminidase inhibitors</title>
            <link>http://www.medworm.com/index.php?rid=2441789&amp;cid=t_97449_109_f&amp;fid=34504&amp;url=http%3A%2F%2Fwww.blacktriangle.org%2Fblog%2F%3Fp%3D1973</link>
            <description>I have a new article in The Pharmaceutical Journal published with a colleague Dr Deborah Layton looking at the neuraminidase inhibitors oseltamivir and zanamivir.
Cox A, Layton D. Adverse drug reactions: Neuraminidase inhibitors: widespread use for influenza may reveal more adverse effects. The Pharmaceutical Journal 2009; 282:621-622
The neuraminidase inhibitors (NAIs), oseltamivir (Tamiflu) and zanamivir (Relenza), are [...] (Source: Black Triangle)</description>
            <author>Black Triangle</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2441789</comments>
            <pubDate>Fri, 22 May 2009 18:22:28 +0100</pubDate>
            <guid isPermaLink="false">2441789</guid>        </item>
        <item>
            <title>Orwell’s adverse drug reaction</title>
            <link>http://www.medworm.com/index.php?rid=2405463&amp;cid=t_97449_109_f&amp;fid=34504&amp;url=http%3A%2F%2Fwww.blacktriangle.org%2Fblog%2F%3Fp%3D1963</link>
            <description>The Guardian has an interesting piece on Orwell and the writing of 1984. The information about the treatment of Orwell&amp;#8217;s tuberculosis (TB) seems to indicate that he suffered a fairly severe skin hypersensivity reaction to streptomycin.

&amp;#8220;In 1947 there was no cure for TB - doctors prescribed fresh air and a regular diet - but there [...] (Source: Black Triangle)</description>
            <author>Black Triangle</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2405463</comments>
            <pubDate>Sun, 10 May 2009 23:38:52 +0100</pubDate>
            <guid isPermaLink="false">2405463</guid>        </item>
        <item>
            <title>Drug metabolism - How drug metabolism influences treatment outcomes</title>
            <link>http://www.medworm.com/index.php?rid=2313667&amp;cid=t_97449_109_f&amp;fid=34504&amp;url=http%3A%2F%2Fwww.blacktriangle.org%2Fblog%2F%3Fp%3D1944</link>
            <description>On Friday 17th April 2009 you could attend a one day course at Aston University on drug metabolism.
Drug metabolism exerts a powerful influence on drug action - from complete failure of a drug&amp;#8217;s effectiveness to life-threatening toxicity. This course focuses on the aims, responses and processes of human drug biotransformation systems. As a result, it [...] (Source: Black Triangle)</description>
            <author>Black Triangle</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2313667</comments>
            <pubDate>Mon, 06 Apr 2009 17:12:14 +0100</pubDate>
            <guid isPermaLink="false">2313667</guid>        </item>
        <item>
            <title>Adverse drug reactions and in-patients</title>
            <link>http://www.medworm.com/index.php?rid=2182288&amp;cid=t_97449_109_f&amp;fid=34504&amp;url=http%3A%2F%2Fwww.blacktriangle.org%2Fblog%2F%3Fp%3D1901</link>
            <description>An important study in the UK looks at the occurance of adverse drug reactions in hospital in-inpatients. It&amp;#8217;s a six month study of in-patients at a Liverpool hospital, and can be considered a follow-up on the study on ADRs seen at admission in the BMJ.
Over six months, there were a total of 3695 patient episodes [...] (Source: Black Triangle)</description>
            <author>Black Triangle</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2182288</comments>
            <pubDate>Thu, 12 Feb 2009 01:44:37 +0100</pubDate>
            <guid isPermaLink="false">2182288</guid>        </item>
        <item>
            <title>A case of mass psychogenic illness?</title>
            <link>http://www.medworm.com/index.php?rid=2147458&amp;cid=t_97449_109_f&amp;fid=34504&amp;url=http%3A%2F%2Fwww.blacktriangle.org%2Fblog%2F%3Fp%3D1890</link>
            <description>Here&amp;#8217;s an interesting report of a series of vaccine reactions:
A group of schoolchildren in Luton were taken to hospital after complaining that they felt unwell following an injection this morning (January 30).
Seven students from Year 10 at Icknield High School were taken to the Luton &amp;#038; Dunstable Hospital as they became ill immediately after receiving [...] (Source: Black Triangle)</description>
            <author>Black Triangle</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2147458</comments>
            <pubDate>Fri, 30 Jan 2009 22:05:58 +0100</pubDate>
            <guid isPermaLink="false">2147458</guid>        </item>
        <item>
            <title>Antipsychotics and stroke: the story to date</title>
            <link>http://www.medworm.com/index.php?rid=2094665&amp;cid=t_97449_109_f&amp;fid=34504&amp;url=http%3A%2F%2Fwww.blacktriangle.org%2Fblog%2F%3Fp%3D1869</link>
            <description>Deborah Layton and I have a brief article in The Pharmaceutical Journal this week on the subject of antispychotics and the evidence for the risk of stroke associated with their use.
Layton D, Cox A. Antipsychotics and stroke: the story to date. The Pharmaceutical Journal 2009; 282: 30
You have to register to read it. (Source: Black Triangle)</description>
            <author>Black Triangle</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2094665</comments>
            <pubDate>Sat, 10 Jan 2009 10:06:03 +0100</pubDate>
            <guid isPermaLink="false">2094665</guid>        </item>
        <item>
            <title>Patient reporting of adverse drug reactions</title>
            <link>http://www.medworm.com/index.php?rid=2094666&amp;cid=t_97449_109_f&amp;fid=34504&amp;url=http%3A%2F%2Fwww.blacktriangle.org%2Fblog%2F%3Fp%3D1868</link>
            <description>Cox A. Involving patients in reporting adverse drug reactions should be welcomed. The Pharmaceutical Journal 2009; 282: 16-17
Patients are no longer the passive recipients of drug therapy instigated by medical professionals. There is increasing patient engagement in individual decisions about their own drug therapy, public discussions about the provision of high cost drugs in the [...] (Source: Black Triangle)</description>
            <author>Black Triangle</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2094666</comments>
            <pubDate>Sat, 10 Jan 2009 09:57:50 +0100</pubDate>
            <guid isPermaLink="false">2094666</guid>        </item>
        <item>
            <title>Rimonabant withdrawal and conflicts of interest</title>
            <link>http://www.medworm.com/index.php?rid=1901190&amp;cid=t_97449_109_f&amp;fid=34504&amp;url=http%3A%2F%2Fwww.blacktriangle.org%2Fblog%2F%3Fp%3D1852</link>
            <description>The EMEA&amp;#8217;s Committee for Medicinal Products for Human Use (CHMP) have pulled the marketing authorisation for rimonabant (Acomplia) [PDF]. This isn&amp;#8217;t much of a surprise. What is interesting in this case is the reasoning, which not only addresses safety concerns, but also concerns about effectiveness in clinical practice (as opposed to clinical trials). Effectiveness, rather [...] (Source: Black Triangle)</description>
            <author>Black Triangle</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1901190</comments>
            <pubDate>Thu, 23 Oct 2008 21:06:21 +0100</pubDate>
            <guid isPermaLink="false">1901190</guid>        </item>
        <item>
            <title>Regulators, the public, and blogs</title>
            <link>http://www.medworm.com/index.php?rid=1802560&amp;cid=t_97449_109_f&amp;fid=34504&amp;url=http%3A%2F%2Fwww.blacktriangle.org%2Fblog%2F%3Fp%3D1838</link>
            <description>In times gone by regulatory bodies concerned with drugs were a black box. Decisions were made and conveyed to the public, with little explanation. Other concerns, that were preliminary and yet to be confirmed by further evidence might be delayed. Public engagement with regulators was minimal. For a number of years things have been changing.
The [...] (Source: Black Triangle)</description>
            <author>Black Triangle</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1802560</comments>
            <pubDate>Thu, 18 Sep 2008 08:51:46 +0100</pubDate>
            <guid isPermaLink="false">1802560</guid>        </item>
        <item>
            <title>Unrestrained badly regulated capitalism kills</title>
            <link>http://www.medworm.com/index.php?rid=1802561&amp;cid=t_97449_109_f&amp;fid=34504&amp;url=http%3A%2F%2Fwww.blacktriangle.org%2Fblog%2F%3Fp%3D1842</link>
            <description>Capitalism kills. There is no better example of that principle than in China. The most recent example in the news tonight is that of contaminated baby milk.
China says it will launch nationwide testing of all dairy products following the deaths of three babies from contaminated milk formula.
More than 6,200 babies have fallen ill after drinking [...] (Source: Black Triangle)</description>
            <author>Black Triangle</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1802561</comments>
            <pubDate>Wed, 17 Sep 2008 23:13:30 +0100</pubDate>
            <guid isPermaLink="false">1802561</guid>        </item>
        <item>
            <title>Seeding trials and missed opportunities</title>
            <link>http://www.medworm.com/index.php?rid=1729290&amp;cid=t_97449_109_f&amp;fid=34504&amp;url=http%3A%2F%2Fwww.blacktriangle.org%2Fblog%2F%3Fp%3D1827</link>
            <description>There is an excellent paper at the Archives of Internal Medicine describing a seeding trial. The authors of the paper helpfully provide a useful and concise description of a such a trial:
Seeding trials are clinical trials designed by pharmaceutical companies to promote the use of pharmacotherapies that were recently approved or are under review by [...] (Source: Black Triangle)</description>
            <author>Black Triangle</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1729290</comments>
            <pubDate>Sat, 23 Aug 2008 21:53:10 +0100</pubDate>
            <guid isPermaLink="false">1729290</guid>        </item>
        <item>
            <title>Recent publications and presentations</title>
            <link>http://www.medworm.com/index.php?rid=1729291&amp;cid=t_97449_109_f&amp;fid=34504&amp;url=http%3A%2F%2Fwww.blacktriangle.org%2Fblog%2F%3Fp%3D1826</link>
            <description>Apologies for the lack of posting here in August. I&amp;#8217;ve been traveling for reasons of both business and pleasure. Here are a couple of recent non-blog related items I have written. 
Cox AR, Wood KMG, Marriott JF, Ferner RE. Causality and definitions: How general practitioners decide what to report to spontaneous reporting schemes. Pharmacoepidemiology and [...] (Source: Black Triangle)</description>
            <author>Black Triangle</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1729291</comments>
            <pubDate>Sat, 23 Aug 2008 20:39:09 +0100</pubDate>
            <guid isPermaLink="false">1729291</guid>        </item>
        <item>
            <title>Want Fewer Side Effects? Test More People</title>
            <link>http://www.medworm.com/index.php?rid=1683440&amp;cid=t_97449_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F356571056%2F</link>
            <description>Seems simple, yes? And so a group of Duke University researchers developed a hypothetical model to estimate the expected incremental number of adverse drug events that could be avoided once a drug is widely available. The upshot: &amp;#8220;Requiring larger preapproval databases could be a cost-effective means of reducing adverse events in post-approval populations,&amp;#8221; they write in Health Affairs.
As you may recall, most industry-sponsored clinical trials of new drugs are designed to determine efficacy in order to gain regulatory approval. But the researchers note that detecting adverse drug events is &amp;#8220;rarely considered when sample-size calculations are undertaken for clinical trials.&amp;#8221; Thus, the statistical power to find side effects is &amp;#8220;inherently a by-product&amp;#8221; of...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1683440</comments>
            <pubDate>Tue, 05 Aug 2008 17:39:31 +0100</pubDate>
            <guid isPermaLink="false">1683440</guid>        </item>
        <item>
            <title>The harms and benefits of medicines</title>
            <link>http://www.medworm.com/index.php?rid=1645733&amp;cid=t_97449_109_f&amp;fid=34504&amp;url=http%3A%2F%2Fwww.blacktriangle.org%2Fblog%2F%3Fp%3D1821</link>
            <description>Adverse drug reactions (ADRs) are a massive burden on the NHS, and a significant cause of morbidity and mortality. When I worked on a cardiology ward, one of the more serious ADRs that occurred was severe haemorrhage associated with streptokinase. Rather than dying of a heart attack, the drug we gave to patients to improve [...] (Source: Black Triangle)</description>
            <author>Black Triangle</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1645733</comments>
            <pubDate>Wed, 23 Jul 2008 06:39:41 +0100</pubDate>
            <guid isPermaLink="false">1645733</guid>        </item>
        <item>
            <title>Good old-fashioned jacked-up antibiotics</title>
            <link>http://www.medworm.com/index.php?rid=1436718&amp;cid=t_97449_109_f&amp;fid=34504&amp;url=http%3A%2F%2Fwww.blacktriangle.org%2F%2Fwordpress%2Fwp-content%2Famericancliche.mp3</link>
            <description>Just testing Podpress. Risk-benefit discussion from American Cliche. (Source: Black Triangle)</description>
            <author>Black Triangle</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1436718</comments>
            <pubDate>Mon, 12 May 2008 09:43:21 +0100</pubDate>
            <guid isPermaLink="false">1436718</guid>        </item>
        <item>
            <title>Assessing, managing and reporting adverse drug reactions</title>
            <link>http://www.medworm.com/index.php?rid=1388837&amp;cid=t_97449_109_f&amp;fid=34504&amp;url=http%3A%2F%2Fwww.blacktriangle.org%2Fblog%2F%3Fp%3D1773</link>
            <description>Because all medicines have the potential to cause adverse effects, the safety of prescribed medicines is a central concern for health professionals. The initial decision to resort to pharmacological treatment, the choice of drug, and the management and monitoring of the patient require knowledge of drug-induced disease. Additionally, a wider public health duty exists for [...] (Source: Black Triangle)</description>
            <author>Black Triangle</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1388837</comments>
            <pubDate>Mon, 21 Apr 2008 08:53:48 +0100</pubDate>
            <guid isPermaLink="false">1388837</guid>        </item>
        <item>
            <title>Snowdon: Teashop closed</title>
            <link>http://www.medworm.com/index.php?rid=1369635&amp;cid=t_97449_109_f&amp;fid=34504&amp;url=http%3A%2F%2Fwww.blacktriangle.org%2Fblog%2F%3Fp%3D1762</link>
            <description>Y Lliwedd, taken on the way down as the clouds lifted.
On Friday I made a quick ascent of Snowdon from Pen-y-Pass using the easy Miners track, before a conference at Bangor University. I had the choice of mountain biking in the rain, or walking in snow about 550m. The second seemed the drier option, so [...] (Source: Black Triangle)</description>
            <author>Black Triangle</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1369635</comments>
            <pubDate>Sun, 13 Apr 2008 22:07:07 +0100</pubDate>
            <guid isPermaLink="false">1369635</guid>        </item>
        <item>
            <title>Children and medicines</title>
            <link>http://www.medworm.com/index.php?rid=1362344&amp;cid=t_97449_109_f&amp;fid=34504&amp;url=http%3A%2F%2Fwww.blacktriangle.org%2Fblog%2F%3Fp%3D1759</link>
            <description>The past few weeks have had a few interesting papers published on the subject of medicines and children. Children are often ill-served by medication, partly due to the difficulties associated with medication use in children and running clinical trials, and partly because of pharmaceutical companies lack of interest in obtaining paediatric licences for a small [...] (Source: Black Triangle)</description>
            <author>Black Triangle</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1362344</comments>
            <pubDate>Wed, 09 Apr 2008 23:30:07 +0100</pubDate>
            <guid isPermaLink="false">1362344</guid>        </item>
        <item>
            <title>Safety signals</title>
            <link>http://www.medworm.com/index.php?rid=1327411&amp;cid=t_97449_109_f&amp;fid=34504&amp;url=http%3A%2F%2Fwww.blacktriangle.org%2Fblog%2F%3Fp%3D1747</link>
            <description>So what happens when you report a suspected adverse drug reaction to a scheme like the UK&amp;#8217;s Yellow Card scheme or the US Medwatch scheme? Although individual reports are examined, large amounts of data can be used to look for drug safety signals. Such signals are a sign that an adverse effect may be associated [...] (Source: Black Triangle)</description>
            <author>Black Triangle</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1327411</comments>
            <pubDate>Wed, 26 Mar 2008 00:48:33 +0100</pubDate>
            <guid isPermaLink="false">1327411</guid>        </item>
        <item>
            <title>Adverse Drug Reactions Are A Big Killer: Study</title>
            <link>http://www.medworm.com/index.php?rid=1311465&amp;cid=t_97449_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F253758249%2F</link>
            <description>More than 3 percent of all deaths seem to be caused by adverse reactions to medical drugs, according to new research, according to a report in Nature. If substantiated by further work, this would make fatal adverse drug reactions the 7th most common cause of death in Sweden, where the research was done.
James Ritter, the editor-in-chief of the British Journal of Clinical Pharmacology, which published the research, calls the finding &amp;#8220;striking.&amp;#8221; “It is a surprisingly high figure,” Donald Singer, a pharmacology expert at the University of Warwick, tells Nature, while wondering if the results can easily be generalized to other areas.
Adverse drug reactions are known to be responsible for between 3 percent and 12 percent of hospital admissions, and fatal drug reactions account f...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1311465</comments>
            <pubDate>Tue, 18 Mar 2008 17:26:32 +0100</pubDate>
            <guid isPermaLink="false">1311465</guid>        </item>
        <item>
            <title>Similar sounding drug (factory) names</title>
            <link>http://www.medworm.com/index.php?rid=1241728&amp;cid=t_97449_109_f&amp;fid=34504&amp;url=http%3A%2F%2Fwww.blacktriangle.org%2Fblog%2F%3Fp%3D1722</link>
            <description>There are plenty of instances of similar sounding drug names causing confusion and adverse events in patients, but this is the first time I&amp;#8217;ve seen a similar sounding pharmaceutical factory causing adverse drug reactions.
The Chinese facility that supplies the active ingredient of the widely used blood thinner heparin was never inspected by the Food and [...] (Source: Black Triangle)</description>
            <author>Black Triangle</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1241728</comments>
            <pubDate>Tue, 19 Feb 2008 16:36:01 +0100</pubDate>
            <guid isPermaLink="false">1241728</guid>        </item>
        <item>
            <title>Patient reporting</title>
            <link>http://www.medworm.com/index.php?rid=1223612&amp;cid=t_97449_109_f&amp;fid=34504&amp;url=http%3A%2F%2Fwww.blacktriangle.org%2Fblog%2F%3Fp%3D1719</link>
            <description>I&amp;#8217;m quoted in this article at The Pharmaceutical Journal in relation to general practitioner reporting.
“It is really important that we don’t lose the bedrock of GPs because they have the most intense relationships with patients,” said Anthony Cox, a pharmacovigilance pharmacist for the West Midlands Centre for Adverse Drug Reactions.
“There has been a slight dip [...] (Source: Black Triangle)</description>
            <author>Black Triangle</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1223612</comments>
            <pubDate>Mon, 11 Feb 2008 23:10:11 +0100</pubDate>
            <guid isPermaLink="false">1223612</guid>        </item>
        <item>
            <title>The culture of ADR reporting</title>
            <link>http://www.medworm.com/index.php?rid=1216444&amp;cid=t_97449_109_f&amp;fid=34504&amp;url=http%3A%2F%2Fwww.blacktriangle.org%2Fblog%2F%3Fp%3D1717</link>
            <description>I am quoted in tomorrow&amp;#8217;s BMJ in an article entitled Most doctors still don’t report adverse reactions to drugs. My comments were made at the Medicines and Healthcare Products Regulatory Agency conference in Birmingham this Monday.
Anthony Cox, a pharmacist at the West Midlands Centre for Adverse Drug Reactions, studied what motivates a GP to report [...] (Source: Black Triangle)</description>
            <author>Black Triangle</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1216444</comments>
            <pubDate>Thu, 07 Feb 2008 23:53:49 +0100</pubDate>
            <guid isPermaLink="false">1216444</guid>        </item>
        <item>
            <title>Risk Management of Medicines in EU: Current Experience - Future Direction</title>
            <link>http://www.medworm.com/index.php?rid=1153926&amp;cid=t_97449_109_f&amp;fid=34504&amp;url=http%3A%2F%2Fwww.blacktriangle.org%2Fblog%2F%3Fp%3D1699</link>
            <description>There are still places available at the MHRA conference, Risk Management of Medicines in EU: Current Experience - Future Direction, on the 4th of February. I&amp;#8217;ll be speaking about my qualitative research into the motivating factors which influence general practitioners&amp;#8217; decisions to report adverse drug reactions to the Yellow Card scheme. (Source: Black Triangle)</description>
            <author>Black Triangle</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1153926</comments>
            <pubDate>Tue, 15 Jan 2008 23:03:51 +0100</pubDate>
            <guid isPermaLink="false">1153926</guid>        </item>
        <item>
            <title>Impossible PR job? I think not</title>
            <link>http://www.medworm.com/index.php?rid=1103376&amp;cid=t_97449_109_f&amp;fid=34504&amp;url=http%3A%2F%2Fwww.blacktriangle.org%2Fblog%2F%3Fp%3D1691</link>
            <description>Craig Brown writes:
A reader of my parodic A-Z of Eth!cal PR column by Su Barking has kindly sent in a cutting from the magazine PR Week, dated November 9, 2007.
&amp;#8220;Clew Communications is to provide PR support for the relaunch of the controversial drug Thalidomide,&amp;#8221; it reads.
A photograph of the MD of Clew Communications, Mary Hicks, [...] (Source: Black Triangle)</description>
            <author>Black Triangle</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1103376</comments>
            <pubDate>Tue, 18 Dec 2007 14:52:55 +0100</pubDate>
            <guid isPermaLink="false">1103376</guid>        </item>
        <item>
            <title>Recent drug safety issues</title>
            <link>http://www.medworm.com/index.php?rid=1039976&amp;cid=t_97449_109_f&amp;fid=34504&amp;url=http%3A%2F%2Fwww.blacktriangle.org%2Fblog%2F%3Fp%3D1672</link>
            <description>Lots of interesting things happening. The withdrawal of lumiracoxib is covered at adr.org.uk, as are the serious skin reactions to strontium ranelate. The NPC cover recent changes to rosiglitazone&amp;#8217;s licence brought in by the FDA, and the psychiatric effects of rimonabant. (Source: Black Triangle)</description>
            <author>Black Triangle</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1039976</comments>
            <pubDate>Tue, 20 Nov 2007 23:29:18 +0100</pubDate>
            <guid isPermaLink="false">1039976</guid>        </item>
        <item>
            <title>Fifty years ago this month thalidomide was launched</title>
            <link>http://www.medworm.com/index.php?rid=945279&amp;cid=t_97449_109_f&amp;fid=34504&amp;url=http%3A%2F%2Fwww.blacktriangle.org%2Fblog%2F%3Fp%3D1654</link>
            <description>It was the thalidomide disaster that first captured public attention about the risks associated with drugs and ensured that major regulatory changes in drug safety would occur throughout the world, including the UK. Paradoxically, thalidomide was initially introduced and marketed to address a serious safety concern. In the 1950s barbiturates were in widespread use. However, [...] (Source: Black Triangle)</description>
            <author>Black Triangle</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=945279</comments>
            <pubDate>Fri, 12 Oct 2007 08:51:16 +0100</pubDate>
            <guid isPermaLink="false">945279</guid>        </item>
        <item>
            <title>Early signal</title>
            <link>http://www.medworm.com/index.php?rid=882343&amp;cid=t_97449_109_f&amp;fid=34504&amp;url=http%3A%2F%2Fwww.blacktriangle.org%2Fblog%2F%3Fp%3D1647</link>
            <description>Here&amp;#8217;s a piece of history, I believe this is the first drug safety signal detected by the Yellow Card scheme published in the BMJ in 1964.
Cahal, DA. Jaundice and Cardivix. British Medical Journal 1964; 2(5413): 882 (Source: Black Triangle)</description>
            <author>Black Triangle</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=882343</comments>
            <pubDate>Tue, 18 Sep 2007 21:03:45 +0100</pubDate>
            <guid isPermaLink="false">882343</guid>        </item>
        <item>
            <title>Spontaneous reporting - still important</title>
            <link>http://www.medworm.com/index.php?rid=682039&amp;cid=t_97449_109_f&amp;fid=34504&amp;url=http%3A%2F%2Fwww.blacktriangle.org%2Fblog%2F%3Fp%3D1596</link>
            <description>In the wake of the concerns about rosiglitazone and cardiovascular events, a response at the BMJ arguing that spontaneous reporting is still of importance. (Source: Black Triangle)</description>
            <author>Black Triangle</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=682039</comments>
            <pubDate>Wed, 20 Jun 2007 13:40:04 +0100</pubDate>
            <guid isPermaLink="false">682039</guid>        </item>
        <item>
            <title>Reazioni indesiderate oculari indotte da farmaci</title>
            <link>http://www.medworm.com/index.php?rid=682040&amp;cid=t_97449_109_f&amp;fid=34504&amp;url=http%3A%2F%2Fwww.blacktriangle.org%2Fblog%2F%3Fp%3D1595</link>
            <description>I have just received copies of my paper published in the Italian Adverse Drug Reaction Bulletin:
Cox AR, Gilmartin B. Reazioni indesiderate oculari indotte da farmaci. Adverse Drug Reaction Bulletin 2007; 174: 697-700 (Source: Black Triangle)</description>
            <author>Black Triangle</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=682040</comments>
            <pubDate>Tue, 19 Jun 2007 12:22:11 +0100</pubDate>
            <guid isPermaLink="false">682040</guid>        </item>
        <item>
            <title>Topical overdose</title>
            <link>http://www.medworm.com/index.php?rid=673820&amp;cid=t_97449_109_f&amp;fid=34504&amp;url=http%3A%2F%2Fwww.blacktriangle.org%2Fblog%2F%3Fp%3D1590</link>
            <description>Here&amp;#8217;s a reminder that one should read instructions and treat all medicines, including non-prescription ones, with respect. A 17-year-old athlete has died folllowing excessive use of an over-the-counter topical anti-inflammatory sports rub:
Arielle Newman, a cross-country runner at Notre Dame Academy on Staten Island, died after her body absorbed high levels of methyl salicylate, an anti-inflammatory [...] (Source: Black Triangle)</description>
            <author>Black Triangle</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=673820</comments>
            <pubDate>Mon, 11 Jun 2007 12:32:31 +0100</pubDate>
            <guid isPermaLink="false">673820</guid>        </item>
        <item>
            <title>Recent Drug Safety News</title>
            <link>http://www.medworm.com/index.php?rid=658448&amp;cid=t_97449_109_f&amp;fid=34504&amp;url=http%3A%2F%2Fwww.blacktriangle.org%2Fblog%2F%3Fp%3D1589</link>
            <description>Recent MHRA Drug Safety news. (Source: Black Triangle)</description>
            <author>Black Triangle</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=658448</comments>
            <pubDate>Tue, 05 Jun 2007 20:35:36 +0100</pubDate>
            <guid isPermaLink="false">658448</guid>        </item>
        <item>
            <title>Thalidomide</title>
            <link>http://www.medworm.com/index.php?rid=622783&amp;cid=t_97449_109_f&amp;fid=34504&amp;url=http%3A%2F%2Fwww.blacktriangle.org%2Fblog%2F%3Fp%3D1585</link>
            <description>As a counterpoint to the post about the mouse, it is worth remembering that sometimes suspicions of harm can be true. Here are thirteen facts about thalidomide, some of which you might not have known.

Chemie Grünenthal, who developed thalidomide (Contergan in Germany, Distaval in the UK), had two drugs pulled from the market prior to [...] (Source: Black Triangle)</description>
            <author>Black Triangle</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=622783</comments>
            <pubDate>Sat, 19 May 2007 22:58:04 +0100</pubDate>
            <guid isPermaLink="false">622783</guid>        </item>
        <item>
            <title>A mouse of my acquaintance…</title>
            <link>http://www.medworm.com/index.php?rid=610742&amp;cid=t_97449_109_f&amp;fid=34504&amp;url=http%3A%2F%2Fwww.blacktriangle.org%2Fblog%2F%3Fp%3D1582</link>
            <description>I&amp;#8217;m currently sat in the British Library sifting my way though various tomes concerned with adverse drug reactions, and have come across the following interesting poem about causation by W.R. Espy, buried within a discussion about detection of adverse events:
A mouse of my acquaintance in seven days was fed
Twice twenty thousand swordfish, and now that [...] (Source: Black Triangle)</description>
            <author>Black Triangle</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=610742</comments>
            <pubDate>Wed, 16 May 2007 14:33:29 +0100</pubDate>
            <guid isPermaLink="false">610742</guid>        </item>
        <item>
            <title>Have times changed?</title>
            <link>http://www.medworm.com/index.php?rid=517223&amp;cid=t_97449_109_f&amp;fid=34504&amp;url=http%3A%2F%2Fwww.blacktriangle.org%2Fblog%2F%3Fp%3D1570</link>
            <description>&amp;#8220;the number of new preparations or new formulations of previously available drugs introduced each year is enormous. Many of these have little virtue and some are stupid or useless mixtures of drugs which add little to modern medicine except expense and unnecessarily increase the number of chemicals a human being is asked to take. Their [...] (Source: Black Triangle)</description>
            <author>Black Triangle</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=517223</comments>
            <pubDate>Mon, 02 Apr 2007 19:42:58 +0100</pubDate>
            <guid isPermaLink="false">517223</guid>        </item>
        <item>
            <title>Pesky ADRs</title>
            <link>http://www.medworm.com/index.php?rid=486919&amp;cid=t_97449_132_f&amp;fid=35011&amp;url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2Fmndoci%2F%7E3%2F102643126%2F</link>
            <description>A new medicinal chemistry blog has an interesting post about &amp;#8220;idiosyncratic&amp;#8221; drug reactions, adverse reactions that occur in a small set of patients. For any number of reasons, trying to get a handle on unpredictable ADRs in small patient subpopulations is critical for the pharmaceutical industry. I am no authority on such ADRs and suggest reading the original post for more information, including references and the authors views.
Currently, idiosyncratic ADRs are not predictable since their mechanisms are not well understood. This is where I believe that translational research is going to play a strong role. Can we identify potential biomarkers (either metabolic markers or genotypes or anything else) that can help identify potential patient subpopulations that might suffer from...</description>
            <author>business|bytes|genes|molecules</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=486919</comments>
            <pubDate>Sun, 18 Mar 2007 20:06:20 +0100</pubDate>
            <guid isPermaLink="false">486919</guid>        </item>
        <item>
            <title>Recognition and management of drug-induced blood disorders</title>
            <link>http://www.medworm.com/index.php?rid=425056&amp;cid=t_97449_109_f&amp;fid=34504&amp;url=http%3A%2F%2Fwww.blacktriangle.org%2Fblog%2F%3Fp%3D1568</link>
            <description>Here&amp;#8217;s a copy of my article Recognition and management of drug-induced blood disorders that was published on the 5th of February 2007 in Prescriber. Obviously, given the massive subject this is, a short article of this nature does not address the detailed management of blood dyscrasias, but I hope it alerts people to the possibility [...] (Source: Black Triangle)</description>
            <author>Black Triangle</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=425056</comments>
            <pubDate>Mon, 19 Feb 2007 20:56:44 +0100</pubDate>
            <guid isPermaLink="false">425056</guid>        </item>
        <item>
            <title>Which came first, chicken or the pill?</title>
            <link>http://www.medworm.com/index.php?rid=409427&amp;cid=t_97449_109_f&amp;fid=34504&amp;url=http%3A%2F%2Fwww.blacktriangle.org%2Fblog%2F%3Fp%3D1555</link>
            <description>Any comments about the vet, involved in the H5N1 virus clear-up, admitted to hospital with what is described as mild non-specific symptoms, or a mild respiratory illness are pure speculation. The government are arguing that H4N1 infection is unlikely because of the precautionary measures taken - which makes sense.
One of those precautionary measures is the [...] (Source: Black Triangle)</description>
            <author>Black Triangle</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=409427</comments>
            <pubDate>Wed, 07 Feb 2007 07:30:57 +0100</pubDate>
            <guid isPermaLink="false">409427</guid>        </item>
    </channel>
</rss>

